BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

Core Viewpoint - BioStem Technologies, Inc. will release its fourth quarter and full year 2025 financial results on March 24, 2026, and will host a conference call and webcast at 4:30 PM ET [1]. Group 1: Company Overview - BioStem Technologies is a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products for regenerative medicine [1][3]. - The company utilizes a proprietary BioRetain processing method, which is designed to maintain growth factors and preserve tissue structure [3]. - BioStem's quality management system has been accredited by the American Association of Tissue Banks and complies with current Good Tissue Practices and Good Manufacturing Processes [3]. Group 2: Upcoming Events - The upcoming conference call and webcast will feature an overview of the quarter presented by CEO Jason Matuszewski and CFO Brandon Poe [2]. - Registration for the event is available through a provided link [2]. Group 3: Contact Information - For further inquiries, BioStem can be contacted via their website, email, or social media platforms [5].